Inhibition of ghrelin action in vitro and in vivo by an RNA-Spiegelmer

Proceedings of the National Academy of Sciences of the United States of America
Steffen HelmlingSven Klussmann

Abstract

Employing in vitro selection techniques, we have generated biostable RNA-based compounds, so-called Spiegelmers, that specifically bind n-octanoyl ghrelin, the recently discovered endogenous ligand for the type 1a growth hormone secretagogue (GHS) receptor. Ghrelin is a potent stimulant of growth hormone release, food intake, and adiposity. We demonstrate that our lead compound, L-NOX-B11, binds ghrelin with low-nanomolar affinity and inhibits ghrelin-mediated GHS-receptor activation in cell culture with an IC(50) of 5 nM. l-NOX-B11 is highly specific for the bioactive, n-octanoylated form of ghrelin. Like the GHS receptor, it does not recognize the inactive unmodified peptide and requires only the N-terminal five amino acids for the interaction. The i.v. administration of polyethylene glycol modified l-NOX-B11 efficiently suppresses ghrelin-induced growth hormone release in rats. These results demonstrate that the neutralization of circulating bioactive ghrelin leads to inhibition of ghrelin's secretory effects in the CNS.

References

Aug 30, 1990·Nature·A D Ellington, J W Szostak
Dec 15, 1996·The Journal of Clinical Investigation·B J HickeD Parma
Sep 1, 1996·Nature Biotechnology·S KlussmannJ P Fürste
Oct 8, 1999·The Journal of Clinical Investigation·T OstendorfJ Floege
Nov 1, 2000·Nature·M TschöpM L Heiman
Nov 18, 2000·European Journal of Endocrinology·L M SeoaneC Dieguez
Dec 22, 2000·European Journal of Endocrinology·R PeinoF F Casanueva
Jan 3, 2001·The Journal of Clinical Endocrinology and Metabolism·K TakayaK Nakao
Feb 24, 2001·Nature·M NakazatoS Matsukura
Apr 6, 2001·Diabetes·M TschöpM L Heiman
Apr 27, 2001·Endocrine·R G SmithA Howard
Sep 11, 2001·Biochemical and Biophysical Research Communications·M MatsumotoK Kangawa
Oct 27, 2001·Diabetes·A M WrenS R Bloom
Dec 12, 2001·The Journal of Clinical Endocrinology and Metabolism·A M WrenS R Bloom
May 25, 2002·The New England Journal of Medicine·David E CummingsJonathan Q Purnell
Jun 5, 2002·The Journal of Clinical Investigation·Yujin ShutoIchiji Wakabayashi
Jun 19, 2002·Proceedings of the National Academy of Sciences of the United States of America·Britta WlotzkaSven Klussmann
Jul 2, 2002·Nature Medicine·David E CummingsDavid S Weigle
Dec 6, 2002·The Journal of Clinical Endocrinology and Metabolism·Angelo DelParigiP Antonio Tataranni
Apr 8, 2003·Current Topics in Medicinal Chemistry·Tamas L HorvathMatthias Tschöp
May 29, 2003·Current Pharmaceutical Design·Tamas L HorvathMatthias H Tschöp
Jun 26, 2003·Nucleic Acids Research·Michael Zuker
Jul 5, 2003·The Journal of Clinical Endocrinology and Metabolism·David E Cummings, Michael H Shannon
Oct 31, 2003·Molecular and Cellular Biology·Yuxiang SunRoy G Smith
May 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·Katherine E WortleyMark W Sleeman

❮ Previous
Next ❯

Citations

Jun 22, 2007·Analytical and Bioanalytical Chemistry·Teresa MairalCiara K O'Sullivan
Dec 25, 2010·Pharmaceutical Research·Renger F Witkamp
Sep 11, 1991·Biochimica Et Biophysica Acta·R NakayamaK Saito
Aug 30, 1991·Clinica Chimica Acta; International Journal of Clinical Chemistry·S J CooneyB A Baldo
Jan 1, 1992·Life Sciences·A TokumuraH Tsukatani
Jul 1, 1995·Journal of Lipid Mediators and Cell Signalling·D S WoodardL M McManus
Jan 1, 1996·The International Journal of Biochemistry & Cell Biology·S AntonopoulouC Iatrou
Jun 21, 2005·Biochimie·C PestourieF Duconge
Mar 30, 1988·Biochemical and Biophysical Research Communications·R NakayamaK Saito
May 1, 1997·The International Journal of Biochemistry & Cell Biology·V AvramopoulouC A Demopoulos
May 4, 2012·Journal of the American Chemical Society·Charles OleaGerald F Joyce
Aug 28, 2013·Journal of the American Chemical Society·Jonathan T Sczepanski, Gerald F Joyce
Jun 2, 2005·Nature Reviews. Cancer·Dario Neri, Roy Bicknell
Jul 2, 2010·Nature Reviews. Drug Discovery·Anthony D KeefeAndrew Ellington
Jul 21, 2006·Nucleic Acids Research·Florian JaroschSven Klussmann
Dec 20, 2007·Neuroreport·Kerstin U BilikThomas Riediger
Jan 9, 2010·Annual Review of Pharmacology and Toxicology·P R BouchardK M Thompson
Apr 24, 2012·Journal of Obesity·Christine Delporte
Dec 3, 2005·The Journal of Clinical Investigation·Kevin L Grove, Michael A Cowley
Apr 18, 2009·Endocrinology·Timothy H Moran, Megan J Dailey
Mar 8, 2008·Endocrine Journal·Simoni A KatergariNikos K Nikolettos
Apr 28, 2010·European Journal of Endocrinology·Amparo RomeroRuben Nogueiras
Feb 1, 2014·Molecular Therapy. Nucleic Acids·Sven KruspeUlrich Hahn
Apr 9, 2013·Indian Journal of Endocrinology and Metabolism·Alfonso Abizaid, Tamas L Horvath
Sep 30, 2014·Obesity Research & Clinical Practice·Takahiro SatoMasayasu Kojima
Feb 7, 2014·British Medical Bulletin·Benjamin C T Field
Aug 28, 2010·International Journal of Peptides·Johannes D Veldhuis, Cyril Y Bowers
Aug 13, 2008·Expert Opinion on Therapeutic Targets·João-Bruno SoaresAdelino Leite-Moreira
Apr 23, 2009·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Weihua Pan, Gary A Clawson
Sep 1, 2007·Expert Opinion on Drug Discovery·Aniela WochnerMartina Rimmele
May 24, 2011·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·G A Martos-Moreno, J Argente
Mar 2, 2011·Molecular and Cellular Endocrinology·Ralf NassMichael O Thorner
Apr 15, 2011·Molecular and Cellular Endocrinology·Miski ScerifMárta Korbonits
Feb 25, 2011·Molecular and Cellular Endocrinology·Miski ScerifMárta Korbonits
Jan 19, 2010·Nutrition·Carine De VrieseChristine Delporte
Nov 10, 2009·Frontiers in Neuroendocrinology·T R CastañedaM H Tschöp
Jun 30, 2009·Pharmacology & Therapeutics·Marianne T Neary, Rachel L Batterham

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.